T-Oncology Revenue

Biotechnology Research • Steinhausen, Zug, Switzerland • 1-10 Employees

T-Oncology revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at T-Oncology

Christian Weh

Chief Executive Officer

Company overview

Headquarters	Parkstrasse 6, Steinhausen, Schweiz (+41) 6312, CH
NAICS	541714
Founded	2022
Employees	1-10

About T-Oncology

T-Oncology AG is focusing on improving patients´ lifes and helping caregivers to have options in the treatment of cancer. Our company works from a proprietary development platform to select small domain antibody fragments to develop drug conjugates to aim at well-known targets (HER2+), but also new ones. (Please inquire for more details) Our initial mission is aiming at the unmet need to target brain metastasis from HER2+ lung, breast, bladder and colonrectal cancer. We will not give up, for you to have an option and hope!

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

T-Oncology has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

T-Oncology has never raised funding before.

Frequently asked questions

T-Oncology is located in Steinhausen, Zug, CH.

T-Oncology generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

T-Oncology has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

T-Oncology was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

T-Oncology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at T-Oncology

Christian Weh

Chief Executive Officer

4.8

40,000 users